End of the vincristine/steroid pulse era in pediatric ALL?, “trial and error” with abatacept in GVHD, and hemorrhage risk with dasatinib therapy
Blood Podcast
00:00
Introduction
No survival benefit for Vin Christine steroid pulses in contemporary studies of childhood acute lymphoblastic leukemia. Abaticept may be a promising strategy for the treatment of acute graft versus host disease, or GVHD. And last on the podcast, the hemorrhage risk of dasatinib therapy.
Transcript
Play full episode
